Lycia Therapeutics: CFO Amy Bachrodt received 399,746 shares

What happened

• Amy Bachrodt, chief financial officer, received a grant of 399,746 shares on Aug 11, 2026. The reported price is $0.00 and the transaction is listed as a derivative award (code A).

Key details

• Transaction date and price: Aug 11, 2026; $0.00 per share.
• Transaction type: Award/grant of derivative securities (code A).
• Shares owned after the transaction: not specified in the provided filing information.
• Footnote F1: The transaction occurred prior to the issuer's registration of a class of equity securities under Section 12 in connection with the issuer's initial public offering and is reported pursuant to Rule 16a-2(a).
• Footnote F2: The award vests 1/4 of the total on Jun 2, 2027, with an additional 1/48 of the total vesting monthly thereafter, subject to continued service.
• Form 4 filing date: Oct 26, 2026 (period of report: Aug 11, 2026).

Why it may matter

• This filing reports an award of derivative securities that vest over time; it is not a market purchase or sale of existing shares.
• A filing does not show why the insider traded or why the company acted.